Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × pomalidomide × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 79 Recurrence 17 Neoplasms 7 Neoplasms, Plasma Cell 3 Lymphoma, Non-Hodgkin 3 Sarcoma, Kaposi 2 Leukemia, Myeloid, Acute 2 Immunoglobulin Light-chain Amyloidosis 2 Chromosome 17 deletion 2 Acquired Immunodeficiency Syndrome 2 Waldenstrom Macroglobulinemia 1 Smoldering Multiple Myeloma 1 Proteostasis Deficiencies 1 Plasmacytoma 1 Plasmablastic Lymphoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Epstein-Barr Virus Infections 1 Burkitt Lymphoma 1 Alzheimer Disease 1

Interventions

ruxolitinib 19 Cyclophosphamide 11 Whole-Body Irradiation 9 Tacrolimus 8 fludarabine phosphate 7 fludarabine 7 Stem Cell Transplantation 7 Mycophenolic Acid 7 Specimen Handling 6 Peripheral Blood Stem Cell Transplantation 6 Azacitidine 5 Melphalan 4 Busulfan 4 Biopsy 4 fedratinib 3 Sirolimus 3 Methotrexate 3 Injections 3 venetoclax 2 selinexor 2 navitoclax 2 luspatercept 2 letermovir 2 itacitinib 2 bomedemstat 2 INCB057643 2 INCB039110 2 Hematopoietic Stem Cell Transplantation 2 Decitabine 2 Cyclosporine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡